At the Federation of Clinical Immunology Societies (FOCiS) Annual Meeting, held June 8-11, researchers driving discovery in the field of translational immunology discussed the latest developments in the field. In this blog, we highlight our poster and industry tutorial presented at the meeting.
Poster: Machine learning approaches to developing TCR repertoire-based diagnostics for pathogen exposure
Paul Fields, Senior Manager Computational Biology, Adaptive Biotechnologies, presented a poster titled, Machine learning approaches to developing TCR repertoire-based diagnostics for pathogen exposure. Explore findings and learn how the immunoSEQ® Technology and machine learning approaches were used to identify disease-specific TCRB sequences for CMV, COVID-19, and gather insights on HLA.
Watch on-demand: Adaptive Biotechnologies Industry Tutorial at FOCIS 2021
Thomas Snyder, VP Research at Adaptive Biotechnologies, presented an industry tutorial, Turning large-scale immune repertoire data into actionable insights: Lessons from COVID-19, other infectious diseases, and autoimmunity. Dr. Snyder discussed:
- The principles behind the Adaptive Biotechnologies immune-medicine platform, particularly the immunoSEQ Technology
- Learnings from over a year of COVID-19 research, including identification of public T-cell receptors to detect recent of past T-cell immune response to infection, track responses to vaccines, and study emerging variants
- The impact of COVID-19 in other therapeutic areas
- Extensions of the technology into other diseases, from assessing prior CMV infection to possibly detecting Lyme disease and Crohn’s disease
For Research Use Only. Not for use in diagnostic procedures.